- Home
- DMF vs SEER Comparison
DMF vs SEER Comparison
Compare DMF & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DMF
- SEER
- Stock Information
- Founded
- DMF 1988
- SEER 2017
- Country
- DMF United States
- SEER United States
- Employees
- DMF N/A
- SEER N/A
- Industry
- DMF Finance/Investors Services
- SEER Medicinal Chemicals and Botanical Products
- Sector
- DMF Finance
- SEER Health Care
- Exchange
- DMF Nasdaq
- SEER Nasdaq
- Market Cap
- DMF 151.3M
- SEER 143.3M
- IPO Year
- DMF N/A
- SEER 2020
- Fundamental
- Price
- DMF $7.02
- SEER $2.31
- Analyst Decision
- DMF
- SEER Hold
- Analyst Count
- DMF 0
- SEER 1
- Target Price
- DMF N/A
- SEER $3.00
- AVG Volume (30 Days)
- DMF 60.7K
- SEER 212.2K
- Earning Date
- DMF 01-01-0001
- SEER 11-06-2024
- Dividend Yield
- DMF 2.66%
- SEER N/A
- EPS Growth
- DMF N/A
- SEER N/A
- EPS
- DMF 0.15
- SEER N/A
- Revenue
- DMF N/A
- SEER $14,608,000.00
- Revenue This Year
- DMF N/A
- SEER N/A
- Revenue Next Year
- DMF N/A
- SEER $34.78
- P/E Ratio
- DMF $45.13
- SEER N/A
- Revenue Growth
- DMF N/A
- SEER N/A
- 52 Week Low
- DMF $5.37
- SEER $1.51
- 52 Week High
- DMF $6.79
- SEER $2.63
- Technical
- Relative Strength Index (RSI)
- DMF 28.05
- SEER 45.81
- Support Level
- DMF $7.40
- SEER $2.20
- Resistance Level
- DMF $7.39
- SEER $2.52
- Average True Range (ATR)
- DMF 0.09
- SEER 0.12
- MACD
- DMF -0.05
- SEER -0.04
- Stochastic Oscillator
- DMF 3.70
- SEER 27.65
About DMF BNY Mellon Municipal Income Inc.
BNY Mellon Municipal Income, Inc. is a non-diversified closed-end management investment company. Its investment objective is to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital. The fund invests in municipal obligations that are rated investment grade and have maturities of less than one year. The company targets to invest in the sector such as education, pre-refunded muni, utility, transportation, healthcare, special tax, state/territory general obligations, industry revenue, and pollution control.
About SEER Seer Inc.
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.